glp-1/gip/glucagon receptor agonist Frontiers Retatrutide—A Game Changer in Obesity
Description
Perkovic, V
Zhou, Q
Congressional Budget Office, which suggested the cost of the drugs could still exceed the savings from treating obesity and its attendant health conditions
10.1111/dom.15529
Contact us today to learn more about our services and how we can support you in achieving optimal wellness through personalized, patient-centered care
